Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service.
about
Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesGas6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritisDabigatran etexilate: an oral direct thrombin inhibitor for prophylaxis and treatment of thromboembolic diseases.Impact of a Pharmacist-Directed Anticoagulation Service on the Quality and Safety of Heparin-Induced Thrombocytopenia Management.Evidence of the economic benefit of clinical pharmacy services: 1996-2000.A systematic review on comparing 2 common models for management of warfarin therapy; pharmacist-led service versus usual medical care.The Impact of Inpatient Versus Outpatient Initiation on Early Warfarin Dosing.Pharmacist-provided anticoagulation management in United States hospitals: death rates, length of stay, Medicare charges, bleeding complications, and transfusions.A review of warfarin dosing and monitoring.Oral anticoagulation in a pediatric hospital: impact of a quality improvement initiative on warfarin management strategiesThe impact of clinical pharmacists on drug-related problems and clinical outcomes.Impact of an inpatient anticoagulation management service on clinical outcomes.Delivery of optimized inpatient anticoagulation therapy: consensus statement from the anticoagulation forum.Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.A pre- post-evaluation of implementing an inpatient warfarin monitoring and education programEffectiveness of pharmacist-participated warfarin therapy management: a systematic review and meta-analysis.Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation.The future of inpatient anticoagulation management.Role of the pharmacist in achieving performance measures to improve the prevention and treatment of venous thromboembolism.The hidden costs of anticoagulation in hospitalized patients with non-valvular atrial fibrillation.Target specific oral anticoagulants in the management of thromboembolic disease in the elderly.Development of an anticoagulation stewardship program at a large tertiary care academic institution.The impact of pharmacy monitoring and intervention in patients receiving intravenous heparin.Implications of an inpatient warfarin dosing nomogram on safety outcomes post-discharge.Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.Initiating warfarin therapy.Clinical Pharmacology 2008: Practical Information for Physicians, Nurses and Pharmacists.Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum.Clinical outcomes and pharmacists' acceptance of a community hospital's anticoagulation management service utilizing decentralized clinical staff pharmacists.Comment on medication management models and other pharmacist interventions: implications for policy and practice.Evaluation of pharmacist-managed dabigatran in an inpatient setting.2006 national clinical pharmacy services survey: clinical pharmacy services, collaborative drug management, medication errors, and pharmacy technology.Challenges and benefits of an inpatient anticoagulation service: one hospital's experience.Impact of clinical pharmacist intervention in anticoagulation clinic in Sudan.Impact of a Guideline for the Management of Antimicrobial/Warfarin Interactions in the Inpatient Setting and Across Transition of Care.
P2860
Q24632951-DFC6062D-8DA4-4F1A-8ACF-14E30E5D29A0Q24672961-3D652743-3343-4D8F-8953-04A87145A307Q33381801-8DE8E129-0C24-4541-A150-A41D33C9CFD6Q33394050-B7C111E2-60CB-4E2E-8A85-B35FFAE33913Q35043395-D6929ECE-7DF4-4A72-A77C-D79E5E7D14EEQ35671241-7EA55F34-EA80-49CD-BCCC-3768ED44A973Q35868100-C7E30656-3E9B-465C-92FB-D3E235450216Q35875442-F519ACB7-0641-431B-8704-1AACD0B91E01Q36348763-9B96BD27-5EA2-46B4-9D3F-B90B7BD22A8AQ36929091-31979878-123B-4855-BC1E-AD0BF613B16AQ37076482-F808917F-0E66-4385-ADB3-6898BD7D4E10Q37156122-758690BA-35F6-4AA0-AA90-2FF9299FC0CBQ37273591-8DCD656D-2517-44BA-9BCA-8496CD99ECA5Q37532484-F2D148C1-C933-47E1-8401-B8CE53884BF7Q37672527-F50109B3-BBBF-409E-A778-A809972BF719Q37787307-9BAD3D02-AFA8-4658-89EC-5607FD4087C1Q37870757-3188A993-3AA4-4292-B7B2-557D5A49E152Q38082467-A1C15FA3-6450-4979-B51C-16765D5CF7B7Q38095824-18E28AFB-7406-4CD4-9058-96DC00F92D98Q38097972-6C815D37-CE6D-4B3D-A915-2F248E5D6F49Q38099775-78DC727C-72D1-4002-9860-B1B187805878Q38170238-955D6329-CFD4-4F04-89D5-EE761771DE02Q38784199-E62EAB22-686A-4FBA-BE3D-9ADA050F91A4Q39096124-60A6C1E0-FDA9-46F2-B787-6D2FCFD4AFC2Q43785099-B5BD10B2-0F26-49D5-97C5-B794D2CD1450Q44457510-B7801269-E069-4C11-B7F9-5CD8FFE61035Q44719730-DBB37D81-3A4B-4426-BA46-0103DAB2AB66Q45052852-44A504A7-0B2C-4B45-A03C-D86511624314Q46076218-7E3C5478-9A48-4423-A0D7-699D78200617Q46093192-2A6059B7-35D6-4942-855D-87732933944AQ46214569-64C9C53B-670A-462C-8EAB-9A1D1D84F556Q46836754-1EE659BA-0B34-4140-B738-DA6400814CA1Q50687784-71F630CE-3B42-4028-87CF-3074EA94C52FQ53494737-5AF9E947-92FD-4CD6-8966-6F8C1A722BECQ53597689-6E4F4064-26C6-4A1E-93B3-E13E2AD83F47
P2860
Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Optimization of inpatient warf ...... naged anticoagulation service.
@en
type
label
Optimization of inpatient warf ...... naged anticoagulation service.
@en
prefLabel
Optimization of inpatient warf ...... naged anticoagulation service.
@en
P2093
P2860
P356
P1476
Optimization of inpatient warf ...... naged anticoagulation service.
@en
P2093
J M Branch
N A Musallam
T E Albertson
P2860
P304
P356
10.1345/APH.18192
P407
P577
2000-05-01T00:00:00Z